Campbell & Co Investment Adviser’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,007
| Closed | -$225K | – | 507 |
|
|
2020
Q2 | $225K | Buy |
+2,007
| New | +$225K | 0.28% | 181 |
|
|
2020
Q1 | – | Sell |
-5,850
| Closed | -$633K | – | 607 |
|
|
2019
Q4 | $633K | Buy |
5,850
+2,777
| +90% | +$300K | 0.19% | 162 |
|
|
2019
Q3 | $301K | Buy |
3,073
+1,055
| +52% | +$103K | 0.11% | 391 |
|
|
2019
Q2 | $264K | Sell |
2,018
-2,665
| -57% | -$349K | 0.12% | 349 |
|
|
2019
Q1 | $633K | Buy |
+4,683
| New | +$633K | 0.31% | 69 |
|
|
2018
Q3 | – | Sell |
-2,306
| Closed | -$286K | – | 571 |
|
|
2018
Q2 | $286K | Buy |
+2,306
| New | +$286K | 0.22% | 208 |
|
|
2017
Q3 | – | Sell |
-3,348
| Closed | -$407K | – | 487 |
|
|
2017
Q2 | $407K | Buy |
+3,348
| New | +$407K | 0.38% | 75 |
|
|
2015
Q1 | – | Sell |
-4,545
| Closed | -$841K | – | 302 |
|
|
2014
Q4 | $841K | Buy |
+4,545
| New | +$841K | 0.52% | 73 |
|
|
2014
Q3 | – | Sell |
-15,681
| Closed | -$2.45M | – | 269 |
|
|
2014
Q2 | $2.45M | Buy |
+15,681
| New | +$2.45M | 0.98% | 40 |
|